ZOON.F Stock Overview

Engages in the research, development, and sale of a range of antimicrobial products in New Zealand, Australasia, Asia, the United States, India, the United Kingdom, and Europe. More details

ZOON.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Risk Analysis

Has less than 1 year of cash runway

Makes less than USD$1m in revenue (NZ$1M)

Does not have a meaningful market cap ($12M)

Earnings have declined by 57% per year over past 5 years

+ 1 more risk

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Zoono Group Limited Competitors

Nano Magic

OTCPK:NMGX

US$9.1m

Nocopi Technologies

OTCPK:NNUP

US$16.2m

American Biltrite

OTCPK:ABLT

US$2.9m

Danimer Scientific

OTCPK:DNMR.Q

US$857.5k

Price History & Performance

Summary of share price highs, lows and changes for Zoono Group
Historical stock prices
Current Share Price	AU$0.015
52 Week High	AU$0.015
52 Week Low	AU$0.01
Beta	1.15
1 Month Change	50.00%
3 Month Change	n/a
1 Year Change	-6.25%
3 Year Change	-87.50%
5 Year Change	-98.75%
Change since IPO	-98.75%

Recent updates

Shareholder Returns

	ZOON.F	US Chemicals	US Market
7D	0%	0.6%	1.3%
1Y	-6.3%	-9.6%	8.2%

Return vs Industry: ZOON.F exceeded the US Chemicals industry which returned -10.6% over the past year.

Return vs Market: ZOON.F underperformed the US Market which returned 7.7% over the past year.

Price Volatility

Is ZOON.F's price volatile compared to industry and market?
ZOON.F volatility
ZOON.F Average Weekly Movement	n/a
Chemicals Industry Average Movement	7.3%
Market Average Movement	7.9%
10% most volatile stocks in US Market	16.4%
10% least volatile stocks in US Market	4.1%

Stable Share Price: ZOON.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine ZOON.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2007	n/a	n/a	zoono.com

Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand, Australasia, Asia, the United States, India, the United Kingdom, and Europe. Its products include hand and surface sanitisers, textile applicator, and mould remediation products. The company serves facilities management, transportation, education, hospitality, and healthcare sectors.

Zoono Group Limited Fundamentals Summary

How do Zoono Group's earnings and revenue compare to its market cap?
ZOON.F fundamental statistics
Market cap	US$7.76m
Earnings (TTM)	-US$2.66m
Revenue (TTM)	US$658.62k

11.8x

P/S Ratio

-2.9x

P/E Ratio

Is ZOON.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZOON.F income statement (TTM)
Revenue	NZ$1.11m
Cost of Revenue	NZ$1.99m
Gross Profit	-NZ$881.03k
Other Expenses	NZ$3.60m
Earnings	-NZ$4.48m

Last Reported Earnings

Dec 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.013
Gross Margin	-79.35%
Net Profit Margin	-403.54%
Debt/Equity Ratio	0%

How did ZOON.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/08 14:12
End of Day Share Price	2025/05/01 00:00
Earnings	2024/12/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zoono Group Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Raju Ahmed	CCZ Equities Pty Limited
Andrew Harrington	CCZ Equities Pty Limited

Zoono Group OTCPK:ZOON.F Stock Report